Global Life Sciences Regulatory Compliance & Submission Solutions from LexisNexis

LexisNexis Life Sciences SolutionsLeverage Our Expertise in Life Sciences
Contact us
Who we serve

LexisNexis Life Sciences Solutions serves many of the world’s top pharmaceutical labelers and medical device manufacturers. With customers from small to mid-size producers and distributors of pharmaceutical and medical device products to the very largest global leaders. Our solutions offer the means to increase productivity, comply with regulations and make more informed decisions quickly.

Medical Devices

Trusted by nearly half of the world’s top 30 medical device manufacturers for specialized UDI compliance solutions.
Learn More

Pharmaceuticals

We provide regulatory consulting, outsourced Structured Product Labeling Services (SPL) for US FDA product listings, eCTD, US Agent and other drug listing & establishment registration services.
Learn More

Cosmetics

We provide regulatory consulting, outsourced Structured Product Labeling Services (SPL) for US FDA product listings, eCTD, US Agent and other drug listing & establishment registration services.

Learn More
Our solutions

Our solutions streamline the collection, transformation, submission, and analysis of regulatory data for medical device and pharmaceutical manufacturers, distributors, and their partners.

PharmaMedical Devices

Data Standards & Transformation

Helping reduce the internal burden of regulatory validation, management, and submission.
PharmaMedical DevicesCosmetics

US Agent Services

We can act as your FDA-required U.S.-based representative.
Pharma

Regulatory Submission Services

Provide expert conversion and submission services with 100% accuracy guaranteed.

Pharma

Labeling & SPL Services

We help you navigate the rigorous SPL process with secure, cloud-based solutions that streamline labeling data management across teams.

Medical Devices

UDI & Device Data Management

Manage UDI data across the product lifecycle in a compliant, scalable SaaS environment built for global requirements.

Cosmetics

Cosmetics (MoCRA) Listing

We streamline MoCRA product listing with efficient, accurate submission and ongoing compliance support.

Pharma

SingleSource™ Drug Products

Manage and submit Unique Device Identification (UDI) data to the health authorities to meet regulatory requirements.

Pharma

Navigator™ for Drug Labels

Search and analyze prescription, OTC, and homeopathic drug label data to quickly find insights, trends, and regulatory information.

View all solutions
How we serve
34%Of FDA GUDID Electronic Records Submitted Annually

750,000+Records Submitted to FDA Global UDI Database

15+Years of Structured Product Labeling Experience

1000+Pharmaceutical customers including manufacturers

99.95%Pharma FDA SPL submissions delivered within contracted time

Upcoming Webinar

March 18, 2026
While the Reed Tech name is being retired, the business has long operated as part of LexisNexis. Customers will continue to work with the same regulatory experts, services, and solutions—now unified within LexisNexis Life Sciences to reflect the broader capabilities and global resources of LexisNexis.

Register nowView all events
Trending resources
5 min read
White paper

EUDAMED Compliance: A Practical Guide for 2025

Achieve EUDAMED Compliance with LexisNexis Life Sciences Solutions. Download our whitepaper for key deadlines, strategies, and insights.

Get the white paper
5 min read
Case study

How Cadwell Implemented a UDI Strategy Customized for a Diagnostic Technology Manufacturer

Cadwell needed to streamline its complex medical device data submission requirement process due to the number of Health and Regulatory Authorities, regions, and divisions involved. In addition, they wanted to gain control over their data which was in disparate sources and spreadsheets.

View case study
5 min read
Cosmetics

Health Canada Announces Mandatory Use of XML Product Monograph in 2025

Health Canada is introducing the mandatory use of the extensible markup language product monograph (XML PM) in phases, with the first phase taking effect on July 18, 2025. This initial phase will require certain submission types to include the XML PM at the time of filing.

View post
5 min Read
PharmaMedical Devices

Approval of OA REMS Advancement

The U.S. Food and Drug Administration (FDA) announced on October 31, 2024, that it has approved a modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS).

View post
5 min Read
Medical Devices

Simplify Your Global Regulatory Compliance with a Singular UDI Vendor

As we continue to discuss optimal solutions to support the growth and compliance needs of industry, LexisNexis Life Sciences Solutions is committed to providing you with a single UDI vendor and platform.

View post
View full Knowledge Center

Trusted by teams at over 300,000 of the world’s leading organizations

What our customers are saying

“Excellent customer and technical support. [LexisNexis Life Sciences Solutions] is a true partner – an extension of our internal resources. Their software solutions are enabling us to successfully meet UDI compliance dates in the US and UK.”

Regulatory DirectorA premier provider of infection prevention and other procedural products and services

“The entire [LexisNexis Life Sciences Solutions] team has supported our numerous clients with SPL generation. Never once have they failed us!”

Operations ManagerRegulatory Professionals Inc.

“[LexisNexis Life Sciences Solutions] has experts in Drug Listing and UDI and we can always count on them for their guidance for the best approach to be taken when needed.”

Operations HeadA global medical device and pharmaceutical maker

Talk to a Life Sciences Regulatory Professional Today

Questions about medical device, pharmaceutical, or cosmetic products or services? We can help.
A LexisNexis regulatory expert will reach out soon.

LexisNexis, a division of RELX Inc., may contact you in your professional capacity with information about our other products, services, and events that we believe may be of interest. You can manage your communication preferences via our Preference Center. You can learn more about how we handle your personal data and your rights by reviewing our Privacy Policy.

Reed Tech is now LexisNexis Life Sciences Solutions

While the Reed Tech name is being retired, the business has long operated as part of LexisNexis. Customers will continue to work with the same regulatory experts, services, and solutions—now unified within LexisNexis Life Sciences to reflect the broader capabilities and global resources of LexisNexis.